These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2479510)
1. [Old and new tumor markers]. Dahlmann N Dtsch Med Wochenschr; 1989 Nov; 114(47):1848-53. PubMed ID: 2479510 [No Abstract] [Full Text] [Related]
2. [Biologic markers of cancer. Towards a selective use for the detection and surveillance of malignant tumors]. Bellet D; Bidart JM Rev Prat; 1989 Nov; 39(26):2350-4. PubMed ID: 2480633 [No Abstract] [Full Text] [Related]
3. [Tumor marker in lung cancer]. Shijubo N; Abe S Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790 [No Abstract] [Full Text] [Related]
9. [Sense and nonsense of tumor markers in practice]. Joss R; Cerny T Schweiz Med Wochenschr; 1990 May; 120(19):693-703. PubMed ID: 1693445 [TBL] [Abstract][Full Text] [Related]
10. Advances in the use of tumor markers. Schwartz MK Compr Ther; 1990 Nov; 16(11):51-7. PubMed ID: 1702695 [No Abstract] [Full Text] [Related]
11. The evaluation of tumor markers levels in determination of surgical procedure in patients with gallbladder carcinoma. Stefanović D; Novaković R; Perisić-Savić M; Djordjević Z; Zivanović M; Stajić S Med Pregl; 1993; 46 Suppl 1():58-9. PubMed ID: 8569609 [TBL] [Abstract][Full Text] [Related]
12. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms]. Ławicki S; Mroczko B; Szmitkowski M Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies in the diagnosis and treatment of malignant conditions. Allum WH; Macdonald F; Fielding JW Surg Annu; 1986; 18():41-64. PubMed ID: 2417343 [No Abstract] [Full Text] [Related]
15. [Serum levels of alpha fetoprotein (AFP), B-chorionic gonadotropin (BHCG), ferritin and prostatic acid phosphatase (PAP) in patients with cancer of the stomach]. Bukowski J; Góźdź S; Słuszniak J; Słuszniak A; Korejba W; Zieliński A; Banasińska E Wiad Lek; 1988 Jul; 41(14):915-20. PubMed ID: 2467444 [No Abstract] [Full Text] [Related]
16. [Dimorphous cancer of the lung]. Briusov PG; Leonova VV Vopr Onkol; 1997; 43(2):205-7. PubMed ID: 9214124 [TBL] [Abstract][Full Text] [Related]
17. [Metastasis and markers]. Trinchieri A; Rovera F; Longo G; Del Nero A; Zanetti G; Austoni E Arch Ital Urol Nefrol Androl; 1992 Mar; 64(1):27-30. PubMed ID: 1373913 [TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of present tumor markers]. Ohkura H Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865 [TBL] [Abstract][Full Text] [Related]
19. Present status of serum tumor markers in diagnosis, prognosis, and evaluation of therapy. Cohn SL; Lincoln ST; Rosen ST Cancer Invest; 1986; 4(4):305-27. PubMed ID: 2429742 [No Abstract] [Full Text] [Related]
20. Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen. Burg-Kurland CL; Purnell DM; Combs JW; Valerio MG; Harris CC; Trump BF Cancer Res; 1986 Nov; 46(11):5730-7. PubMed ID: 2428482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]